We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+1.38%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$23.9B
AUM Growth
-$469M
(-1.9%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
1,935
New
209
Increased
532
Reduced
683
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$392M |
| 2 |
BP
BP
|
+$158M |
| 3 |
General Motors
GM
|
+$152M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$148M |
| 5 |
Amdocs
DOX
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$102M |
| 2 |
Marriott International
MAR
|
+$95.6M |
| 3 |
Fortinet
FTNT
|
+$94.9M |
| 4 |
Cardinal Health
CAH
|
+$91.3M |
| 5 |
Apple
AAPL
|
+$88.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.31% |
| 2 | Consumer Discretionary | 13.19% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Staples | 10.22% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Indivior Pharmaceuticals
INDV
$4.57B
| $49.5M | 0.21% |
2,281,179
-47,527
| -2% | -$1.08M |
|
127
ASE Group
ASX
$83.1B
| $49.2M | 0.21% |
6,549,328
+927,795
| +17% | +$7.21M |
|
|
128
GSK
GSK
$104B
| $48.7M | 0.2% |
1,344,531
-2,862,669
| -68% | -$102M |
|
129
McCormick & Company Non-Voting
MKC
$14.2B
| $48.5M | 0.2% |
641,897
+415,269
| +183% | +$34.7M |
|
|
CYBR
130
DELISTED
CyberArk
CYBR
| $48.4M | 0.2% |
295,893
+205,224
| +226% | +$33M |
|
131
Camtek
CAMT
$7.28B
| $48.4M | 0.2% |
777,124
-36,100
| -4% | -$1.78M |
|
132
Verizon
VZ
$195B
| $47.5M | 0.2% |
1,465,697
-49,480
| -3% | -$1.67M |
|
133
Baker Hughes
BKR
$63.4B
| $47.1M | 0.2% |
1,332,601
+1,211,222
| +998% | +$42.9M |
|
134
Manulife Financial
MFC
$73B
| $46.7M | 0.2% |
2,543,653
-4,482,213
| -64% | -$84.7M |
|
135
Applied Industrial Technologies
AIT
$13.3B
| $46.7M | 0.2% |
301,822
-14,310
| -5% | -$2.15M |
|
136
MSC Industrial Direct
MSM
$6.84B
| $45.5M | 0.19% |
464,201
-171,368
| -27% | -$16.9M |
|
137
UnitedHealth
UNH
$373B
| $45M | 0.19% |
89,338
-107,076
| -55% | -$52.7M |
|
138
Bristol-Myers Squibb
BMY
$133B
| $44.3M | 0.19% |
762,681
-371,495
| -33% | -$22.8M |
|
139
TJX Companies
TJX
$177B
| $44.1M | 0.18% |
496,165
+469,249
| +1,743% | +$41.3M |
|
140
Sherwin-Williams
SHW
$88.1B
| $43.6M | 0.18% |
171,013
+151,251
| +765% | +$40.5M |
|
141
Tesla
TSLA
$1.3T
| $43.2M | 0.18% |
172,652
+19,390
| +13% | +$4.98M |
|
142
Exelixis
EXEL
$13.1B
| $42.8M | 0.18% |
1,957,848
+1,786,687
| +1,044% | +$37.4M |
|
143
iShares Core MSCI EAFE ETF
IEFA
$195B
| $42.7M | 0.18% |
663,219
+277,402
| +72% | +$18.6M |
|
|
SPLK
144
DELISTED
Splunk Inc
SPLK
| $42.3M | 0.18% |
289,288
-138,446
| -32% | -$15.7M |
|
145
Hilton Worldwide
HLT
$70B
| $41.9M | 0.18% |
279,266
-224,959
| -45% | -$34M |
|
146
Campbell Soup
CPB
$6.72B
| $40.9M | 0.17% |
996,140
-806,223
| -45% | -$35.3M |
|
|
MOMO
147
Hello Group
MOMO
$876M
| $40.7M | 0.17% |
5,839,157
+199,128
| +4% | +$1.83M |
|
148
Box
BOX
$4.68B
| $40.4M | 0.17% |
1,668,543
-539,274
| -24% | -$15.4M |
|
149
Elevance Health
ELV
$86.3B
| $39.3M | 0.16% |
90,302
-44,527
| -33% | -$20.2M |
|
150
Coca-Cola Europacific Partners
CCEP
$46.7B
| $38.8M | 0.16% |
620,764
-944,291
| -60% | -$60.1M |
|
Similar funds
Acadian Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Acadian Asset Management held 1,935 positions worth $23.9B, down 1.9% from $24.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Acadian Asset Management's Q3 2023 filing shows 209 new, 532 increased, 683 reduced and 293 closed positions. Its largest new stake was Amdocs: 1,147,499 shares worth $96.9M. The largest sale was GSK, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Acadian Asset Management's largest Q3 2023 buy was Amdocs: 1,147,499 shares worth $96.9M.
- Acadian Asset Management added most to Stellantis in Q3 2023, an estimated $392M increase.
- Acadian Asset Management's biggest Q3 2023 reduction was GSK, cutting an estimated $102M.
- Acadian Asset Management fully exited KE Holdings in Q3 2023, selling an estimated $49.5M.
- Acadian Asset Management's ten largest holdings make up 21% of its $23.9B portfolio in Q3 2023.
- Acadian Asset Management opened 209 new positions and closed 293 in Q3 2023.
- Acadian Asset Management's portfolio value fell 1.9% quarter-over-quarter to $23.9B.
Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.